Back to signals
FDA device recallVulnerabilitiesPublished October 30, 2025
Dexcom, Inc.: Integrated Continuous Glucose Monitoring System, Factory Calibrated
A software defect in version v1.15.0 of the G6 Android app can cause the app to terminate unexpectedly, which may result in the user not receiving estimated glucose values, alarms, alerts or notifications. This could result in the missed detection of a hyperglycemic or hypoglycemic event, protentional resulting in severe hyperglycemia, diabetic ketoacidosis (DKA), or hyperosmolar hyperglycemic state (HHS).
Open the source record- Tags
- FDA recall, medical device, class 2, Clinical Chemistry, Software Design Change, Open, Classified
- Related exam domains
- CISSP 3: Security Architecture and Engineering; CISSP 7: Security Operations; CISSP 8: Software Development Security
- Source record id
- Z-0318-2026
- First seen by InfoSec Signals
- 9/23/2026
Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.